Health Care Archives - Page 9 of 478

2 minute read

Sanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients

June 4, 3:18 PM

Sanofi's phase 3 IMROZ study shows Sarclisa with VRd significantly improves progression-free survival in newly diagnosed, transplant-ineligible multiple myeloma patients.

SNY

2 minute read

Nano-Cap Equillium Shares Fall After Patchy Hair Loss Study Data

By Vandana Singh

June 4, 12:35 PM

Equillium released topline data from its Phase 2 study of EQ101 in adult patients with alopecia areata, a disease that results in patchy hair loss.

2 minute read

Mid-Cap Firm Annexon’s Nerve Disorder Candidate Shows Promise In Pivotal Late-Stage Study

By Vandana Singh

June 4, 12:06 PM

Annexon reports positive Phase 3 trial results for ANX005 in Guillain-Barré syndrome, showing significant improvements in disability, muscle strength, and ventilation duration.

ANNX

1 minute read

Bristol Myers Squibb Announces Phase 3 Results Of Opdivo/Yervoy Combo In Liver Cancer Patients

By Vandana Singh

June 4, 11:35 AM

Opdivo plus Yervoy combo shows significant survival benefits and higher response rates vs. lenvatinib/sorafenib in HCC.

BMY

1 minute read

This MedTech Company Has Market Expansion Opportunity, Says Bullish Analyst

By Priya Nigam

June 4, 11:10 AM

Strong data from TransMedics' clinical trials is expected to drive adoption. Longer-term, the annual market opportunity is $1.5 billion.

TMDX

2 minute read

What’s Going On With Viking Therapeutics Stock On Tuesday?

By Vandana Singh

June 4, 10:29 AM

Viking Therapeutics reports promising 52-week data from its Phase 2b VOYAGE study on VK2809 for NASH.

VKTX

2 minute read

Nano-Cap Spruce Biosciences Collaborates With HMNC Brain Health To Develop Treatment for Major Depressive Disorder

By Vandana Singh

June 4, 7:02 AM

Spruce Biosciences collaborates with HMNC Brain Health to advance tildacerfont, a precision therapeutic for major depressive disorder, using the Cortibon Genetic Selection Tool.

SPRB

2 minute read

Johnson & Johnson Ordered To Pay $260M In Latest Talc Trial

By Benzinga Neuro

June 4, 1:58 AM

The ruling comes as J&J continues to pursue a proposed $6.48 billion settlement of most talc-related lawsuits through a prepackaged bankruptcy.

JNJ

2 minute read

HealthEquity Stock Climbs After Better-Than-Expected Q1 Results, Strong Forward Guidance

By Erica Kollmann

June 3, 4:32 PM

HealthEquity shares are climbing after the company reported its first-quarter financial results Monday. Here's a look at the highlights from the report.

HQY

2 minute read

Structure Therapeutics’ Obesity Candidate Is ‘ Very Competitive’ To Eli Lilly’s Orforglipron, Analyst Says

By Vandana Singh

June 3, 3:14 PM

Structure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290, showing a 6.2% weight loss. Cantor Fitzgerald maintains an Overweight rating with a $65 target

GPCR